TELA Bio Inc (TELA)

NASD · Healthcare · Medical Devices · USA

TELA Bio Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

TELA Bio Inc is a medical technology company providing soft-tissue reconstruction solutions designed to preserve and restore patient anatomy. The company offers OviTex Reinforced Tissue Matrix for hernia repair and abdominal wall reconstruction, and OviTex PRS for plastic and reconstructive surgery. TELA Bio markets its products through a direct sales force primarily in the U.S. and Europe.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the TELA Bio Inc stock.

Our verdict on TELA

Undervalued: intrinsic value $2.72 per share, market price $0.76, margin of safety 72.1% (as of 2026-11-17).

A 1.6x revenue multiple, discounted for its losses, values the shares at $2.72; the price of $0.76 is 72% below that value.

ETFs with the most weight in TELA

More on TELA

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than TELA in Medical Devices

Is TELA undervalued or overvalued?

TELA is undervalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $2.72; the price of $0.76 is 72% below that value.

What is the intrinsic value of TELA?

$2.72 per share (as of the 2026-11-17 close), against a market price of $0.76. That is a margin of safety of 72.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.